Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Nuvalent Inc | 4,571,678 | 5,000,000 | +428,322 | $346.81M | $511.50M | 17.90% | +$164.69M |
| Arcellx Inc COMMON STOCK | 3,848,095 | 4,000,000 | +151,905 | $212.38M | $334.04M | 11.69% | +$121.66M |
| argenx SEADR(ARGX) | 538,139 | 480,374 | -57,765 | $231.42M | $260.40M | 9.11% | +$28.98M |
| Revolution Medicines, Inc.(RVMD) | 5,259,089 | 5,314,089 | +55,000 | $204.11M | $240.99M | 8.43% | +$36.89M |
| Crinetics Pharmaceuticals In | 2,513,302 | 2,516,686 | +3,384 | $112.57M | $128.60M | 4.50% | +$16.03M |
| Merus N V | 2,019,814 | 2,454,917 | +435,103 | $119.51M | $122.65M | 4.29% | +$3.14M |
| Janux Therapeutics, Inc.(JANX) | 1,564,452 | 2,400,574 | +836,122 | $65.53M | $109.06M | 3.82% | +$43.52M |
| Kura Oncology, Inc.(KURA) | 4,539,381 | 4,331,321 | -208,060 | $93.47M | $84.63M | 2.96% | -$8.83M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 2,435,416 | 2,440,445 | +5,029 | $66.19M | $80.27M | 2.81% | +$14.07M |
| Edgewise Therapeutics, Inc.(EWTX) | 2,325,449 | 2,789,172 | +463,723 | $41.88M | $74.44M | 2.61% | +$32.56M |
| Disc Medicine, Inc.(IRON) | 2,704,718 | 1,497,720 | -1,206,998 | $121.90M | $73.60M | 2.58% | -$48.30M |
| Vaxcyte, Inc.(PCVX) | 627,202 | 627,732 | +530 | $47.36M | $71.73M | 2.51% | +$24.37M |
| Viridian Therapeutics, Inc.(VRDN) | 2,896,349 | 2,895,689 | -660 | $37.68M | $65.88M | 2.31% | +$28.20M |
| Olema Pharmaceuticals, Inc.(OLMA) | 7,903,600 | 5,503,600 | -2,400,000 | $85.52M | $65.71M | 2.30% | -$19.80M |
| Arvinas, Inc.(ARVN) | 2,438,149 | 2,339,961 | -98,188 | $64.90M | $57.63M | 2.02% | -$7.27M |
| Y-Mabs Therapeutics Inc | 3,870,594 | 4,086,346 | +215,752 | $46.76M | $53.74M | 1.88% | +$6.98M |
| Cogent Biosciences, Inc.(COGT) | 3,624,342 | 4,609,762 | +985,420 | $30.55M | $49.79M | 1.74% | +$19.23M |
| Vera Therapeutics, Inc.CL A(VERA) | 0 | 1,096,851 | +1,096,851 | $0 | $48.48M | 1.70% | +$48.48M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 0 | 931,480 | +931,480 | $0 | $46.97M | 1.64% | +$46.97M |
| BeOne Medicines AGADR(ONC) | 0 | 200,336 | +200,336 | $0 | $44.98M | 1.57% | +$44.98M |
| Immatics N.V.SHS(IMTX) | 3,421,965 | 3,904,862 | +482,897 | $39.76M | $44.55M | 1.56% | +$4.79M |
| Apogee Therapeutics Inc | 330,000 | 701,817 | +371,817 | $12.99M | $41.22M | 1.44% | +$28.24M |
| Immunovant, Inc.(IMVT) | 1,362,827 | 1,362,827 | 0 | $35.98M | $38.85M | 1.36% | +$2.88M |
| Cullinan Therapeutics, Inc.(CGEM) | 1,542,805 | 2,321,013 | +778,208 | $26.91M | $38.85M | 1.36% | +$11.95M |
| Spyre Therapeutics, Inc.(SYRE) | 0 | 1,267,581 | +1,267,581 | $0 | $37.28M | 1.30% | +$37.28M |
| Pliant Therapeutics, Inc.(PLRX) | 0 | 3,104,486 | +3,104,486 | $0 | $34.80M | 1.22% | +$34.80M |
| Keros Therapeutics, Inc.(KROS) | 0 | 525,037 | +525,037 | $0 | $30.49M | 1.07% | +$30.49M |
| Erasca, Inc.(ERAS) | 7,250,000 | 10,668,141 | +3,418,141 | $17.11M | $29.12M | 1.02% | +$12.01M |
| Oruka Therapeutics, Inc.(ORKA) | 0 | 719,660 | +719,660 | $0 | $17.64M | 0.62% | +$17.64M |
| Perspective Therapeutics, Inc.(CATX) | 919,692 | 919,692 | 0 | $9.17M | $12.28M | 0.43% | +$3.11M |
| COMPASS Pathways plcADS(CMPS) | 2,335,926 | 1,160,000 | -1,175,926 | $14.11M | $7.31M | 0.26% | -$6.80M |
| Acrivon Therapeutics Inc | 659,724 | 0 | -659,724 | $3.83M | $0 | — | -$3.83M |
| ALX Oncology Holdings Inc.(ALXO) | 1,575,605 | 0 | -1,575,605 | $9.50M | $0 | — | -$9.50M |
| Ascendis Pharma A/SADR(ASND) | 664,307 | 0 | -664,307 | $90.60M | $0 | — | -$90.60M |
| BridgeBio Pharma, Inc.(BBIO) | 1,089,492 | 0 | -1,089,492 | $27.60M | $0 | — | -$27.60M |
| Cerevel Therapeutics Hldng I | 2,330,508 | 0 | -2,330,508 | $95.29M | $0 | — | -$95.29M |
| Legend Biotech CorporationADS(LEGN) | 1,203,308 | 0 | -1,203,308 | $53.29M | $0 | — | -$53.29M |
| Sarepta Therapeutics, Inc.(SRPT) | 947,574 | 0 | -947,574 | $149.72M | $0 | — | -$149.72M |
| TScan Therapeutics, Inc.(TCRX) | 353,886 | 0 | -353,886 | $2.07M | $0 | — | -$2.07M |
| Verona Pharma PlcADS | 721,087 | 0 | -721,087 | $10.43M | $0 | — | -$10.43M |
| Vor Biopharma Inc.(VOR) | 6,457,293 | 0 | -6,457,293 | $6.46M | $0 | — | -$6.46M |
| Xenon Pharmaceuticals Inc.(XENE) | 2,043,280 | 0 | -2,043,280 | $79.67M | $0 | — | -$79.67M |